MPH Health Care AG (FRA:93M1) 1-Year Sharpe Ratio: 0.94 (As of Sep. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:93M1 MPH Health Care AG FRA:93M1
63 GF Score
Price €26.80
GF Value €10.02
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is MPH Health Care AG 1-Year Sharpe Ratio?

MPH Health Care AG FRA:93M1 -3.94% 63 1-Year Sharpe Ratio is 0.94 as of Sep. 14, 2026. GuruFocus rates FRA:93M1 with a GF Score™ of 63/100 and a GF Value™ of €10.02 (Significantly Overvalued). The stock has 6 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-09-14), MPH Health Care AG's 1-Year Sharpe Ratio is 0.94.

MPH Health Care AG  (FRA:93M1) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

MPH Health Care AG 1-Year Sharpe Ratio Related Terms

FRA:93M1 vs BLK, BX, KKR: 1-Year Sharpe Ratio Comparison

For the Asset Management subindustry, MPH Health Care AG's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MPH Health Care AG 1-Year Sharpe Ratio vs Asset Management Industry

For the Asset Management industry and Financial Services sector, MPH Health Care AG's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where MPH Health Care AG's 1-Year Sharpe Ratio falls into.


FRA:93M1
63GF Score
MPH Health Care AG FRA:93M1
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MPH Health Care AG 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.94 mean?
MPH Health Care AG (FRA:93M1) has a 1-Year Sharpe Ratio of 0.94 as of Sep. 14, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for MPH Health Care AG and its competitors.
Is MPH Health Care AG's 1-Year Sharpe Ratio too high?
MPH Health Care AG's current 1-Year Sharpe Ratio is 0.94. Overall, MPH Health Care AG has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MPH Health Care AG's 1-Year Sharpe Ratio compare to BLK and BX?
MPH Health Care AG's 1-Year Sharpe Ratio of 0.94 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for an Asset Management company?
A good 1-Year Sharpe Ratio depends on the Asset Management industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for MPH Health Care AG and its competitors. MPH Health Care AG's current 1-Year Sharpe Ratio is 0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPH Health Care AG stock overvalued right now?
Based on GuruFocus' analysis, MPH Health Care AG (FRA:93M1) is currently considered Significantly Overvalued. The stock's GF Value™ is €10.02, compared to a current price of €26.80 — trading 167.5% above its estimated fair value. The current 1-Year Sharpe Ratio is 0.94. MPH Health Care AG's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For MPH Health Care AG (FRA:93M1), the current 1-Year Sharpe Ratio is 0.94 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MPH Health Care AG (FRA:93M1) Overvalued in 2026?

Based on GuruFocus' analysis, MPH Health Care AG stock appears to be overvalued. The current stock price of €26.80 is trading 167.5% above its estimated GF Value™ of €10.02. GuruFocus considers MPH Health Care AG to be Significantly Overvalued.

Key valuation signals for FRA:93M1:

  • 1-Year Sharpe Ratio: 0.94
  • GF Value™: €10.02 vs. price of €26.80 (167.5% above fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the FRA:93M1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MPH Health Care AG Business Description

Other Exchanges 0W1Q:UK93M1:Germany
Address Grunauer Strasse 5, Berlin, DEU, 12557
MPH Health Care AG is an investment company. Its business activities consist of investing in companies with the goal of capital appreciation. The strategic focus of its activities is on the acquisition and development of companies and company shares, particularly in growth segments of the healthcare market and the pharmaceutical industry.
63GF Score

Get the complete analysis for FRA:93M1

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.80
Price
€10.02
GF Value